Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Single tablet regimens are associated with reduced Efavirenz withdrawal in antiretroviral therapy naïve or switching for simplification HIV-infected patients ; volume:14 ; number:1 ; day:13 ; month:1 ; year:2014 ; pages:1-7 ; date:12.2014
BMC infectious diseases ; 14, Heft 1 (13.1.2014), 1-7, 12.2014
- Urheber
-
Fabbiani, Massimiliano
- Beteiligte Personen und Organisationen
-
Zaccarelli, Mauro
Grima, Pierfrancesco
Prosperi, Mattia
Fanti, Iuri
Colafigli, Manuela
D’Avino, Alessandro
Mondi, Annalisa
Borghetti, Alberto
Fantoni, Massimo
Cauda, Roberto
Di Giambenedetto, Simona
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-14-26
- URN
-
urn:nbn:de:1111-2016030314772
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:27 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fabbiani, Massimiliano
- Zaccarelli, Mauro
- Grima, Pierfrancesco
- Prosperi, Mattia
- Fanti, Iuri
- Colafigli, Manuela
- D’Avino, Alessandro
- Mondi, Annalisa
- Borghetti, Alberto
- Fantoni, Massimo
- Cauda, Roberto
- Di Giambenedetto, Simona
- SpringerLink (Online service)
Ähnliche Objekte (12)
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification
Correction to: Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
Abacavir, efavirenz, didanosine, with or without hydroxyurea, in HIV-infected adults failing initial nucleoside/protease inhibitor-containing regimens
Simplification of therapy (ART) with efavirenz/emtricitabine/tenofovir DF single tablet regimen vs. continued ART in suppressed, HIV-infected patients
Modular Titratable Polypills for Personalized Medicine and Simplification of Complex Medication Regimens
Simplification
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d’Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial
Impact of CYP2B6 and CYP2A6 polymorphisms on efavirenz plasma concentrations in Ghanaian HIV-infected patients
Patient-reported outcomes after simplification to a single tablet regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir DF (TDF)
Pharmacodynamics of efavirenz 400 mg in treatment-naïve Chinese HIV-infected patients in a prospective cohort study
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes
Substitution of nevirapine for efavirenz in virologically controlled patients intolerant of efavirenz
Randomization and Simplification